Medquimica develops, manufactures and distributes branded and generic pharmaceutical drugs, both OTC and prescription. Medquimica produces 47 non-complex off-patent drugs, which are replications/copies of off-patent reference drugs of multinationals. The Company has 480 employees and is a mid-sized pharmaceutical player, ranking within the top 35 of roughly 200 companies in Brazil.
Medquimica was acquired by Graycliff Partners on December 01, 2011.
Join Mergr to view all 198 acquisitions of manufacturing companies in 2011, including 95 acquisitions by private equity firms, and 103 by strategics.
Join Mergr to view this profile - and discover more manufacturing acquisitions of companies like Medquimica.
No obligation. Cancel anytime.